Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,118 | 1,346 | 2,953 | 1,027 | 441 |
| Receivables | 948 | 1,215 | 1,108 | 566 | 890 |
| Inventories | 769 | 750 | 758 | 612 | 688 |
| TOTAL | $4,932 | $5,604 | $6,425 | $3,759 | $3,800 |
| Non-Current Assets | |||||
| PPE Net | 8,079 | 8,218 | 7,809 | 7,587 | 7,732 |
| Investments And Advances | 6,027 | 5,140 | 5,141 | 5,141 | 5,158 |
| Intangibles | 1,465 | 1,465 | 1,453 | 468 | 592 |
| Other Non-Current Assets | 753 | 765 | 782 | 780 | 906 |
| TOTAL | $16,323 | $15,587 | $15,185 | $13,976 | $14,388 |
| Total Assets | $21,255 | $21,191 | $21,610 | $17,734 | $18,188 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,572 | 1,608 | 1,429 | 425 | 304 |
| Accounts payable and accrued liabilities | 245 | 435 | 297 | 133 | 578 |
| Accrued Expenses | 0 | 0 | 181 | 419 | 340 |
| Other current liabilities | 339 | 411 | 50 | 54 | 229 |
| TOTAL | $2,155 | $2,453 | $1,957 | $1,031 | $3,251 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,800 | 1,800 | 1,800 | 1,800 | 0 |
| Other Non-Current Liabilities | 1,017 | 1,039 | 1,039 | 785 | 651 |
| TOTAL | $2,808 | $2,811 | $2,831 | $2,558 | $656 |
| Total Liabilities | $4,963 | $5,264 | $4,788 | $3,589 | $3,907 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,043 | 13,796 | 12,590 | 11,380 | 7,981 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -45,415 | -44,825 | -43,921 | -42,720 | -41,256 |
| Other shareholders' equity | -1,292 | -1,304 | -1,417 | -1,499 | -1,657 |
| TOTAL | $16,292 | $15,927 | $16,822 | $14,145 | $14,281 |
| Total Liabilities And Equity | $21,255 | $21,191 | $21,610 | $17,734 | $18,188 |